Shares of Futura Medical plc (LON:FUM – Get Free Report) passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1.01 and traded as low as GBX 0.35. Futura Medical shares last traded at GBX 0.36, with a volume of 3,408,925 shares traded.
Futura Medical Trading Up 11.1%
The stock’s 50-day moving average price is GBX 0.60 and its two-hundred day moving average price is GBX 1. The stock has a market capitalization of £2.33 million, a P/E ratio of -0.14 and a beta of 0.02.
Futura Medical (LON:FUM – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share (EPS) for the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%.The company had revenue of GBX 170 million for the quarter. On average, equities research analysts predict that Futura Medical plc will post 2.8486672 earnings per share for the current year.
About Futura Medical
Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.
Read More
- Five stocks we like better than Futura Medical
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
